title: Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?
abstract: Platelets play a key role in hemostasis but are also responsible for the formation of pathogenic thrombi underlying the acute clinical manifestations of vascular atherothrombotic disease. Platelets are activated by multiple pathways, including adenosine diphosphate (ADP), thromboxane A(2) (TXA(2)), and thrombin, ultimately leading to formation of platelet-rich thrombi that occlude the arterial lumen, resulting in ischemia and cardiovascular events. Current oral antiplatelet agents inhibit the TXA(2) (aspirin [ASA]) and ADP platelet activation pathways (P2Y(12) ADP receptor antagonists) and have demonstrated clinical efficacy for the reduction of morbidity and mortality in patients with atherothrombotic disease. However, these agents are associated with residual risk for thrombotic events, bleeding risk, and variability in response. Thus, there is a strong clinical need for novel antiplatelet therapies that decrease the risk of thrombotic events without exposing patients to increased risk of bleeding. This review describes the clinical safety and efficacy of ASA and P2Y(12) ADP receptor antagonists, the limitations of current antiplatelet therapy, and novel therapies in development, including newer P2Y(12) ADP receptor antagonists and protease-activated receptor (PAR-1) inhibitors.
authors.affiliation: Internal Medicine III, University Hospital Freiburg, Hugstetter Str 55, 79106, Freiburg, Germany. Martin.Moser@uniklinik-freiburg.de
authors.forename: Martin
authors.initials: M
authors.lastname: Moser
authors.forename: Christoph
authors.initials: C
authors.lastname: Bode
mesh_terms: D000284:Administration, Oral; D001777:Blood Coagulation / Q000187:drug effects*; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors
references.citation: J Am Coll Cardiol. 2007 Oct 16;50(16):1541-7
references.pmid: 17936152
references.citation: Circulation. 2003 Oct 7;108(14):1682-7
references.pmid: 14504182
references.citation: Am J Med. 2007 Jul;120(7):631-5
references.pmid: 17602938
references.citation: N Engl J Med. 2005 Mar 24;352(12):1179-89
references.pmid: 15758000
references.citation: BMJ. 2002 Jan 12;324(7329):71-86
references.pmid: 11786451
references.citation: Circulation. 2008 Oct 14;118(16):1626-36
references.pmid: 18757948
references.citation: Curr Med Chem Cardiovasc Hematol Agents. 2003 Mar;1(1):37-45
references.pmid: 15317289
references.citation: Lancet. 2001 Aug 18;358(9281):527-33
references.pmid: 11520521
references.citation: Lancet. 2008 Apr 19;371(9621):1353-63
references.pmid: 18377975
references.citation: J Pharmacol Exp Ther. 2003 Feb;304(2):855-61
references.pmid: 12538843
references.citation: J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16
references.pmid: 17418288
references.citation: Platelets. 2001 Jun;12(4):197-209
references.pmid: 11454254
references.citation: N Engl J Med. 2001 Aug 16;345(7):494-502
references.pmid: 11519503
references.citation: Circ Res. 2006 Dec 8;99(12):1293-304
references.pmid: 17158345
references.citation: Lancet. 2009 Feb 28;373(9665):723-31
references.pmid: 19249633
references.citation: J Med Chem. 2008 Jun 12;51(11):3061-4
references.pmid: 18447380
references.citation: Am Heart J. 2009 Sep;158(3):335-341.e3
references.pmid: 19699854
references.citation: N Engl J Med. 2009 Dec 10;361(24):2318-29
references.pmid: 19915221
references.citation: N Engl J Med. 2009 Jan 22;360(4):363-75
references.pmid: 19106083
references.citation: N Engl J Med. 2008 Aug 28;359(9):938-49
references.pmid: 18753650
references.citation: N Engl J Med. 2006 Apr 20;354(16):1706-17
references.pmid: 16531616
references.citation: Am J Cardiol. 2005 Apr 15;95(8):973-5
references.pmid: 15820166
references.citation: Am J Cardiol. 2003 Oct 15;92(8):930-5
references.pmid: 14556868
references.citation: J Thromb Haemost. 2005 Aug;3(8):1800-14
references.pmid: 16102047
references.citation: Thromb Haemost. 2009 Jul;102(1):7-14
references.pmid: 19572061
references.citation: N Engl J Med. 2009 Sep 10;361(11):1045-57
references.pmid: 19717846
references.citation: J Atheroscler Thromb. 2010 Feb 26;17(2):156-64
references.pmid: 20124733
references.citation: Am Heart J. 2005 Oct;150(4):690-4
references.pmid: 16209967
references.citation: Mt Sinai J Med. 2006 Jan;73(1):431-9
references.pmid: 16470323
references.citation: J Am Coll Cardiol. 2007 May 15;49(19):1982-8
references.pmid: 17498584
references.citation: N Engl J Med. 1988 Jun 30;318(26):1714-9
references.pmid: 2967433
references.citation: Lancet. 2009 Jan 24;373(9660):309-17
references.pmid: 19108880
references.citation: Eur Heart J. 2008 Jan;29(1):21-30
references.pmid: 18055486
references.citation: J Am Coll Cardiol. 2006 Oct 3;48(7):1339-45
references.pmid: 17010792
references.citation: Circulation. 2007 Dec 11;116(24):2793-801
references.pmid: 18025530
references.citation: Neurology. 2008 Aug 26;71(9):650-5
references.pmid: 18685137
references.citation: J Am Coll Cardiol. 2006 Nov 7;48(9):1742-50
references.pmid: 17084243
references.citation: Lancet. 1996 Nov 16;348(9038):1329-39
references.pmid: 8918275
references.citation: N Engl J Med. 2009 Jan 22;360(4):354-62
references.pmid: 19106084
references.citation: Circulation. 2006 Aug 22;114(8):774-82
references.pmid: 16908769
references.citation: JAMA. 2004 Oct 20;292(15):1875-82
references.pmid: 15494586
references.citation: N Engl J Med. 2009 Dec 10;361(24):2330-41
references.pmid: 19915222
references.citation: N Engl J Med. 2007 Dec 13;357(24):2482-94
references.pmid: 18077812
references.citation: Circ Res. 2007 May 11;100(9):1261-75
references.pmid: 17495233
references.citation: Circulation. 2004 Jun 29;109(25):3171-5
references.pmid: 15184279
references.citation: Eur Heart J. 2003 Oct;24(20):1815-23
references.pmid: 14563340
references.citation: N Engl J Med. 2007 Nov 15;357(20):2001-15
references.pmid: 17982182
references.citation: Lancet. 2009 Mar 14;373(9667):919-28
references.pmid: 19286091
references.citation: Thromb Haemost. 2009 Aug;102(2):248-57
references.pmid: 19652875
references.citation: Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):766-80
references.pmid: 18957959
references.citation: Eur J Pharmacol. 2003 Jul 25;473(2-3):163-9
references.pmid: 12892834
references.citation: Thromb Haemost. 2009 Jul;102(1):111-9
references.pmid: 19572075
references.citation: JAMA. 2002 Nov 20;288(19):2411-20
references.pmid: 12435254
references.citation: Thromb Haemost. 2004 Aug;92(2):311-6
references.pmid: 15269827
references.citation: Circulation. 2009 Oct 20;120(16):1569-76
references.pmid: 19805650
references.citation: Eur Heart J. 2006 May;27(9):1038-47
references.pmid: 16476694
references.citation: Catheter Cardiovasc Interv. 2003 May;59(1):21-5
references.pmid: 12720236
references.citation: N Engl J Med. 1983 Aug 18;309(7):396-403
references.pmid: 6135989
references.citation: Eur Heart J. 2009 Mar;30(6):655-61
references.pmid: 18713759
references.citation: Eur Heart J. 2006 May;27(10):1166-73
references.pmid: 16621870
references.citation: Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):403-12
references.pmid: 18174460
references.citation: Cardiovasc Drugs Ther. 2009 Dec;23(6):489-99
references.pmid: 19890703
references.citation: Lancet. 2009 May 30;373(9678):1849-60
references.pmid: 19482214
references.citation: Am Heart J. 2009 Dec;158(6):998-1004.e1
references.pmid: 19958867
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):288-92
references.pmid: 17190826
references.citation: Am Heart J. 2009 Sep;158(3):327-334.e4
references.pmid: 19699853
references.citation: Lancet. 2005 Nov 5;366(9497):1607-21
references.pmid: 16271642
references.citation: Circulation. 2009 Apr 14;119(14):1873-82
references.pmid: 19332461
references.citation: BMJ. 2008 Jan 26;336(7637):195-8
references.pmid: 18202034
references.citation: Chest. 2003 Sep;124(3 Suppl):18S-25S
references.pmid: 12970120
references.citation: JAMA. 2004 Oct 6;292(13):1555-62
references.pmid: 15467057
references.citation: J Invasive Cardiol. 2004 Apr;16(4):169-74
references.pmid: 15152138
references.citation: Am J Cardiol. 2005 Nov 1;96(9):1200-6
references.pmid: 16253582